Matthew J. Becker
Intellectual Property Practice Chair
Matt Becker is the Chair of the Intellectual Property practice and has over 25 years of experience trying and litigating a diverse range of patent infringement and trade secret cases. He has tried numerous high-stakes cases to both courts and juries.
Matthew J. Becker
Intellectual Property Practice Chair
Matt Becker is the Chair of the Intellectual Property practice and has over 25 years of experience trying and litigating a diverse range of patent infringement and trade secret cases. He has tried numerous high-stakes cases to both courts and juries.
Serving as lead trial counsel to multinational corporations across the life sciences, consumer products, technology, computer hardware and software, and industrial sectors, Matt has successfully handled more than 100 patent litigations, including numerous trials involving blockbuster drugs. He is often called upon to take over cases mid-stream, based on his proven track record of success.
Matt has particular experience litigating disputes involving intersecting intellectual property and antitrust issues, including matters involving standard-essential patents.
In addition to his patent litigation practice, Matt holds various leadership positions within the firm. He is a member of the firm’s Executive Committee and served as the firm’s managing partner from 2017-2023. Under his guidance, the firm experienced record growth and expansion, acquiring talented lateral partners and expanding its geographic footprint by opening an office in San Francisco to better serve the firm’s West Coast client base.
Matt's accomplishments have earned him recognition as a leading intellectual property litigator by Benchmark Litigation, The National Law Journal, and Chambers.
Experience
- Representation of a major generic pharmaceutical company in Hatch-Waxman patent infringement action pending in the District of New Jersey involving methylphenidate hydrochloride extended-release capsules.
- Defense of pharmaceutical company in Hatch-Waxman litigation pending in the Southern District of Indiana relating to duloxetine hydrochloride capsules.
- Representation of major generic pharmaceutical company in parallel actions in the District of New Jersey and the District of Delaware involving dexmethylphenidate hydrochloride extended release capsules.
- Defense of generic pharmaceutical company in Hatch-Waxman patent litigation relating to atomoxetine hydrochloride capsules.
- Various counseling projects for pharmaceutical companies involving patent analysis relating to Abbreviated New Drug Applications.
- Successful defense to verdict of an international manufacturer of electronic fans and hard drive motors against claims of infringement of multiple patents covering brushless direct current motors used in computer equipment.
- Defense of a major manufacturer of nuclear detection equipment in a patent infringement action involving a nine-figure damage claim in the U.S. District Court in Knoxville, Tennessee, in which a favorable settlement was obtained at the outset of trial.
- Representation in multiple patent and commercial actions of a leading manufacturer of electronic environmental monitors which were favorably resolved through settlement and summary judgment.
- Successful procurement of injunctive relief on behalf of a prominent pharmaceutical manufacturer in a trade secret action against a competitor.
- Representation of aerospace corporation in breach of license agreement claim in which a seven figure settlement was obtained.
- Representation of manufacturer of specialty optical fibers in action alleging infringement of ten patents. Obtained dismissal of claims relating to seven patents, and favorable settlement of remaining claims.
- Representation of a major software manufacturer in a highly publicized business method patent case involving online travel services.
- Defense of a leading manufacturer of hand tools in patent infringement action in which multiple patents were asserted, and in which all claims were dismissed with prejudice following a successful Markman hearing.
- Representation of a Fortune 500 forest products corporation in multiple patent infringement and trade secret litigation matters and in intellectual property strategic counseling.
- Representation of a Fortune 100 corporation in obtaining a multimillion-dollar judgment and permanent injunction after a three-year litigation against a competitor based on the misappropriation and misuse of proprietary drawings and technology.
- Prosecution and defense of various patent infringement lawsuits in the U.S. District Court for the District of Connecticut on behalf of a manufacturer of compact disc labeling equipment and software.
- Defense of a leader in the electronic billing field against patent infringement claims, and negotiation of acquisition of the patent-in-suit.
- Defense of U.S. and German manufacturers of multi-gas analyzers against claims of patent infringement and trade secret misappropriation.
- Successful defense of Fortune 500 corporation in patent infringement action involving pneumatic shears.
Honors
- Lawdragon, 500 Leading Litigators in America (2025)
- LMG Life Sciences – Life Sciences Star (2020 – 2024)
- Named to The National Law Journal’s list of Intellectual Property Trailblazers (2020)
- World's Leading Patent Professionals (2020 – 2024), IAM Patent 1000
- Benchmark Litigation – CT Litigation Star: Intellectual Property (2020 – 2025)
- Best Lawyers in America (2015 – 2025)
- Chambers USA – Connecticut: Litigation (2016 – 2020, 2024)
- Super Lawyers (2012 – 2021; 2023 – 2024)
Education
- JD, summa cum laude – Indiana University School of Law (1991)
- BS, Chemistry – Indiana University (1988)
Admissions
- Connecticut
- U.S. Court of Appeals for the Federal Circuit
- U.S. District Court for the District of Connecticut
- U.S. Patent & Trademark Office
- Judicial Panel Multi-District Litigation
Quotes
He knows patent law inside out" and “is extremely smart and comes up with excellent strategies.
Chambers USA
... Matthew Becker is a seasoned litigator who has an excellent track record of advising large multinational clients in vitally important patent matters.
IAM Patent 1000 2023
News & Insights
News & Insights
Axinn Partners Ranked in the 2025 Edition of Benchmark Litigation
Awards & Recognitions
Intellectual Property
Axinn Partners Named to Lawdragon 500 Leading Litigators in America 2025
Awards & Recognitions
Antitrust
Axinn Attorneys Named to Best Lawyers 2025
Awards & Recognitions
Antitrust
Axinn Shortlisted for 2024 LMG Life Sciences Americas Awards
Awards & Recognitions
Intellectual Property
Chambers USA 2024 Ranks 16 Axinn Lawyers, including 14 Antitrust Partners, and Recognizes the Firm in Seven Jurisdictions
Awards & Recognitions
Antitrust
Axinn and IP Partners Ranked by IAM Patent 1000 2024
Awards & Recognitions
Intellectual Property
ACI 20th Paragraph IV Conference
Speaking Engagement
Intellectual Property
IoT SEP Negotiations: New Players in a Complicated Game
Axinn Viewpoints
Intellectual Property
LMG Life Sciences Selects Axinn Partners as Life Sciences Stars
News
Intellectual Property
Axinn Partners Ranked in the 2024 Edition of Benchmark Litigation
News
Litigation & Trials